Institutional Ownership Sutro Biopharma, Inc. (STRO)
This table provides information about the institutional ownership of Sutro Biopharma, Inc. (STRO). We have compiled data on the 128 institutions that hold shares in the stock, with a total of 59.9 Million shares, which have been reported (via 13F filing form) to have a value of $95.3 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Suvretta Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
7,462,495
shares
|
$11.9 Million
0.57% of portfolio
|
Q4 2024
Added 3.83%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
6,910,730
shares
|
$11 Million
0.0% of portfolio
|
Q2 2024
Added 21.2%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
4,208,500
shares
|
$6.69 Million
0.0% of portfolio
|
Q4 2024
Added 0.32%
|
|
Kynam Capital Management, LP
Princeton, NJ |
Feb 14, 2025 Q4 2024 |
3,641,447
shares
|
$5.79 Million
0.42% of portfolio
|
Q4 2024
Added 76.22%
|
|
Vestal Point Capital, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,570,000
shares
|
$4.09 Million
0.28% of portfolio
|
Q4 2024
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
2,458,657
shares
|
$3.91 Million
0.0% of portfolio
|
Q4 2024
Added 15.61%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
2,197,538
shares
|
$3.49 Million
0.01% of portfolio
|
Q4 2024
Reduced 26.69%
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
2,196,814
shares
|
$3.49 Million
1.24% of portfolio
|
Q2 2024
Added 31.11%
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
2,160,062
shares
|
$3.43 Million
0.59% of portfolio
|
Q4 2024
Reduced 23.73%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,000,000
shares
|
$3.18 Million
0.01% of portfolio
|
Q4 2024
Reduced 11.12%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,854,017
shares
|
$2.95 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.16%
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
1,751,925
shares
|
$2.79 Million
0.01% of portfolio
|
Q4 2024
Added 8.82%
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
1,727,925
shares
|
$2.75 Million
0.46% of portfolio
|
Q4 2024
Added 0.69%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,714,422
shares
|
$2.73 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.82%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,701,870
shares
|
$2.71 Million
0.0% of portfolio
|
Q4 2024
Added 3.32%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,520,136
shares
|
$2.42 Million
0.0% of portfolio
|
Q4 2024
Added 454.62%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,323,777
shares
|
$2.1 Million
0.0% of portfolio
|
Q4 2024
Added 10.35%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
1,136,457
shares
|
$1.81 Million
0.0% of portfolio
|
Q4 2024
Added 15.93%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
1,015,211
shares
|
$1.61 Million
0.0% of portfolio
|
Q4 2024
Added 22.6%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
859,373
shares
|
$1.37 Million
0.01% of portfolio
|
Q4 2024
Added 4.58%
|
|
Eversept Partners, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
694,408
shares
|
$1.1 Million
0.13% of portfolio
|
Q4 2024
Reduced 62.3%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
636,920
shares
|
$1.01 Million
0.0% of portfolio
|
Q4 2024
Added 2.33%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
547,800
shares
|
$871,002
0.0% of portfolio
|
Q4 2024
Reduced 7.29%
|
|
Prudential Financial Inc
Newark, NJ |
Feb 11, 2025 Q4 2024 |
547,510
shares
|
$870,540
0.0% of portfolio
|
Q4 2024
Added 350.96%
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
437,079
shares
|
$694,955
0.22% of portfolio
|
Q4 2024
Added 32.62%
|